Health & Pharm General

FabTab Expands Eco-Friendly Cleaning Line with New Toilet Bowl Cleaner Tablets

🕔2/26/2025 10:44:40 AM

FabTab, a pioneer in sustainable home cleaning, has expanded its product range with the launch of its toilet bowl cleaner tablets - a powerful, eco-friendly alternative to traditional toilet cleaners.

Read Full Article

A' Wearable Technologies Design Award Announces Comprehensive Prize Package for 2024-2025

🕔2/26/2025 6:57:06 AM

The A' Wearable Technologies Design Award, a highly regarded international design competition, announces its comprehensive prize package for the 2024-2025 competition period.

Read Full Article

A' Cybernetics, Prosthesis and Implant Design Award Announces Comprehensive Prize Package for 2024

🕔2/25/2025 6:33:52 AM

The A' Cybernetics, Prosthesis and Implant Design Award has announced its comprehensive prize package for the 2024-2025 competition period, offering an extensive array of benefits designed to celebrate and promote excellence in cybernetics innovation.

Read Full Article

FamilieSCN2A and Cellectricon Partner to Accelerate Drug Development for a Top Autism and Epilepsy Gene, SCN2A

🕔2/24/2025 5:00:00 PM

The FamilieSCN2A Foundation, the leading nonprofit organization in the world dedicated to improving the lives of individuals affected by SCN2A-related disorders (SRDs), is proud to announce a strategic partnership with Cellectricon, a cutting-edge biotechnology company specializing in advanced neuronal assay technologies.

Read Full Article

Kineviz Partners with Ultipa to Unlock Complex Data Relationships and Real-Time Graph Analytics

🕔2/24/2025 2:00:00 PM

FOR IMMEDIATE RELEASE Collaboration Integrates Kineviz’s GraphXR Platform and SightXR AI with Ultipa Powerhouse, the Next-Generation Graph Platform, to Unlock Complex Data Relationships and Real-Time Graph Analytics Ultipa, Inc.

Read Full Article

FamilieSCN2A Foundation Expands Multidisciplinary Care with Children's Hospital Colorado Neurogenetics Clinic

🕔2/24/2025 2:00:00 PM

The FamilieSCN2A is excited to announce a new partnership with Children’s Hospital Colorado Neurogenetics Clinic to expand multidisciplinary care in SCN2A-related disorders (SRDs).

Read Full Article

Memphasys Limited (ASX:MEM) Meets Deadlines and is Preparing for Regulatory Submission, FELIX(TM) Clinical Trial Completed

🕔2/24/2025 11:17:27 AM

Memphasys Limited (ASX:MEM) (FRA:IG7) is pleased to announce successful completion of the data lock for the pivotal Felix(TM) clinical trial. This marks a critical milestone in ensuring the accuracy and integrity of the trial data.

Read Full Article